Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Patrys product shows activity in multiple myeloma cancer cells

Patrys product shows activity in multiple myeloma cancer cells

16 Aug 2011
Amorfix provides update on cancer therapeutic antibody programs

Amorfix provides update on cancer therapeutic antibody programs

12 Aug 2011
NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

NCI, Pharmacyclics sign CRADA to develop PCI-32765 for blood cancers

10 Aug 2011
Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study

Criterium to manage Senesco's SNS01-T Phase Ib/2a multiple myeloma study

9 Aug 2011
Keryx reports net loss of $3.1 million for second quarter 2011

Keryx reports net loss of $3.1 million for second quarter 2011

8 Aug 2011
YM BioSciences reports preclinical results of CYT387 in multiple myeloma

YM BioSciences reports preclinical results of CYT387 in multiple myeloma

5 Aug 2011
ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

ImmunoCellular receives new patent for ICT-69 to treat multiple myeloma, ovarian cancer

4 Aug 2011
ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

4 Aug 2011
Celgene reports second quarter total revenue of $1.18 billion

Celgene reports second quarter total revenue of $1.18 billion

28 Jul 2011
Recruitment complete in Aeterna Zentaris' perifosine Phase 3 trial for advanced colorectal cancer

Recruitment complete in Aeterna Zentaris' perifosine Phase 3 trial for advanced colorectal cancer

27 Jul 2011
Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

Aeterna Zentaris completes AEZS-130 Phase 3 study for diagnosis of AGHD

27 Jul 2011
TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

TikoMed receives FDA Orphan Drug Designation for TM-400 to treat hematological cancers

26 Jul 2011
Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

Adaptimmune announces opening of pilot clinical trial in synovial sarcoma

25 Jul 2011
Australian anti-cancer company completes $2.6 million placement

Australian anti-cancer company completes $2.6 million placement

21 Jul 2011
Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

20 Jul 2011
Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

Johnson & Johnson second quarter sales increase 8.3% to $16.6 billion

19 Jul 2011
Thalidomide analog shows promise against sickle cell disease

Thalidomide analog shows promise against sickle cell disease

19 Jul 2011
Aeterna's AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011

Aeterna's AEZS-108 final Phase 2 results in endometrial cancer to be presented at ESGO 2011

19 Jul 2011
EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events

EC grants marketing authorization for Amgen's XGEVA to prevent skeletal-related events

15 Jul 2011
EPO grants patent for Aeterna Zentaris' perifosine to treat benign, malignant tumours

EPO grants patent for Aeterna Zentaris' perifosine to treat benign, malignant tumours

12 Jul 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback